Aptose Bioscns (APTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
Sales | 5 | 5 | 1 | 0 | 3 |
Cost of Goods | 1 | 1 | 0 | N/A | 0 |
Gross Profit | 4 | 4 | 1 | N/A | 2 |
Operating Expenses | 3,411 | 4,221 | 4,610 | 0 | 4,310 |
Operating Income | -3,406 | -4,216 | -4,609 | N/A | -4,307 |
Interest Expense | 190 | 170 | 160 | 0 | 70 |
Other Income | 66 | 66 | 79 | 0 | 77 |
Pre-tax Income | -3,530 | -4,320 | -4,690 | 0 | -4,300 |
Net Income Continuous | -4,095 | -4,312 | -5,596 | -4,598 | 5,274 |
Net Income | $-4,095 | $-4,312 | $-5,596 | $-4,598 | $5,274 |
EPS Basic Total Ops | -108.10 | -162.14 | -160.18 | -162.14 | 162.14 |
EPS Basic Continuous Ops | -127.17 | -134.75 | -159.43 | -144.14 | 165.33 |
EPS Diluted Total Ops | -108.10 | -162.14 | -160.18 | -162.14 | 162.14 |
EPS Diluted Continuous Ops | -127.17 | -134.75 | -159.43 | -144.14 | 165.33 |
EBITDA(a) | $-1,516 | $-3,586 | $-6,219 | $630 | $-2,737 |